| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.002 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |